CD8A and hepatocellular carcinoma: While ICI could restore the function of exhausted virus‐specific CD8 T cells by PD‐1/PD‐L1 blockade, boosting immune control on HCC growth, it could also disrupt the immune homeostasis in the liver, leading to an increased immune response to hepatocytes and subsequent liver damage.